Cargando…

Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection

Coronavirus disease 2019 (COVID-19) infection is unequivocally the worst crisis in recent decades, which is caused by a severe acute respiratory virus 2. Currently, there is no effective therapy for the COVID-19 infection. Different countries have different guidelines for treating COVID-19 in the ab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajpai, Jyoti, Pradhan, Akshyaya, Verma, Ajay Kumar, Kant, Surya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168786/ https://www.ncbi.nlm.nih.gov/pubmed/35765514 http://dx.doi.org/10.5493/wjem.v12.i3.44

Ejemplares similares

Hydroxychloroquine and COVID-19 – A narrative review
por: Bajpai, Jyoti, et al.
Publicado: (2020)

Remdesivir – Current evidence & perspective in management of COVID-19 infection
por: Bajpai, Jyoti, et al.
Publicado: (2021)

Estimates of Prevalence of Pulmonary Hypertension according to Different International Definitions
por: Tyagi, Richa, et al.
Publicado: (2021)

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
por: Arshad, Samia, et al.
Publicado: (2020)

Oral tuberculosis - Current concepts
por: Sharma, Supriya, et al.
Publicado: (2019)

Curious case of primary pulmonary mucoepidermoid carcinoma
por: Bajpai, Jyoti, et al.
Publicado: (2019)

Coronavirus and cardiovascular manifestations- getting to the heart of the matter
por: Bhandari, Monika, et al.
Publicado: (2021)

Clinical, demographic and radiological profile of smoker COPD versus nonsmoker COPD patients at a tertiary care center in North India
por: Bajpai, Jyoti, et al.
Publicado: (2019)

Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
por: Li, Chunfeng, et al.
Publicado: (2020)

Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19
por: Lauriola, Marinella, et al.
Publicado: (2020)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature
por: Goldman, Jason D., et al.
Publicado: (2021)

Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin
por: Chang, David, et al.
Publicado: (2020)

Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin
por: Gabriels, James, et al.
Publicado: (2020)

Problems with the analysis in “Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19”
por: Atkinson, J. Graham
Publicado: (2020)

Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients
por: Yendrapalli, Usha, et al.
Publicado: (2021)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
por: Albani, Filippo, et al.
Publicado: (2020)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Honoré, Stéphane, et al.
Publicado: (2021)

Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
por: Bernardini, Andrea, et al.
Publicado: (2021)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19
por: Xu, Jiuyang, et al.
Publicado: (2022)

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
por: EL Ouarradi, Amal, et al.
Publicado: (2020)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Clinical, Radiological, and Lung Function Characteristics of Post-tuberculosis Bronchiectasis: An Experience From a Tertiary Care Center in India
por: Bajpai, Jyoti, et al.
Publicado: (2023)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

The Severity of COVID 19 Pneumonia in Vaccinated vs. Non-vaccinated Patients in the Second Wave: An Experience From a Tertiary Care Center in India
por: Bajpai, Jyoti, et al.
Publicado: (2022)

Ventricular Arrhythmia Risk Based on Ethnicity in COVID-19 Patients on Hydroxychloroquine and Azithromycin Combination: Viewpoint
por: Roy, Sayak, et al.
Publicado: (2020)

Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
por: Varisco, Tyler J., et al.
Publicado: (2020)

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Treatment of COVID-19 in pregnancy with hydroxychloroquine and azithromycin: a case report
por: Sisti, Giovanni, et al.
Publicado: (2020)

Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uvcfo40j4onhhjfr2a0d1vg2oo